Neo-adjuvant Immunotherapy in Patients With Localized Melanoma
Abroad (travel likely)RecruitingPHASE2
Conditions
Cutaneous Melanoma, Stage III · Mucosal Melanoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU de Bordeaux- Hôpital Saint-André, Bordeaux, France
Contact: Study coordinator (Caroline DUTRIAUX, MD, PhD) · caroline.dutriaux@chu-bordeaux.fr · +33 05 56 79 47 05Contact: Principal Investigator (Caroline DUTRIAUX, MD, PHD)Centre Léon Bérard, Lyon, France
Contact: Study coordinator (Mona AMINI-ADLE, MD, PhD) · Mona.AMINI-ADLE@lyon.unicancer.fr · +33 04 78 78 59 96Contact: Principal Investigator (Mona AMINI-ADLE, MD, PHD)Hospices Civils de Lyon (Hôpital Lyon Sud), Lyon, France
Contact: Study coordinator (Stéphane DALLE, MD, PhD) · stephane.dalle@chu-lyon.fr · +33 04 78 86 16 79Contact: Principal Investigator (Stéphane DALLE, MD, PHD)AP-HM Marseille (Hôpital de la Timone), Marseille, France
Contact: Study coordinator (Caroline GAUDY-MARQUESTE, MD, PhD) · caroline.gaudy@ap-hm.fr · +33 04 91 38 57 80Contact: Principal Investigator (Caroline GAUDY-MARQUESTE, MD, PHD)AP-HP- Hôpital Saint-Louis, Paris, France
Contact: Principal Investigator (Céleste LEBBÉ, MD, PHD)Gustave Roussy, Villejuif, France
Contact: Study coordinator (Caroline ROBERT, MD, PhD) · Caroline.ROBERT@gustaveroussy.fr · 33(0) 1 42 11 42 53Contact: Principal Investigator (Caroline ROBERT, MD, PHD)